Cas:886762-68-1 1,3-difluoro-5-iodo-2-methoxybenzene manufacturer & supplier

We serve Chemical Name:1,3-difluoro-5-iodo-2-methoxybenzene CAS:886762-68-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1,3-difluoro-5-iodo-2-methoxybenzene

Chemical Name:1,3-difluoro-5-iodo-2-methoxybenzene
CAS.NO:886762-68-1
Synonyms:PC9917;2,5-DIDEOXY-2,5-IMINO-D-MANNITOL HCL;2,6-Difluoro-4-iodoanisole
Molecular Formula:C7H5F2IO
Molecular Weight:270.01500
HS Code:2909309090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:9.23000
Exact Mass:269.93500
LogP:2.57800

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like PC9917 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,6-Difluoro-4-iodoanisole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,PC9917 Use and application,2,5-DIDEOXY-2,5-IMINO-D-MANNITOL HCL technical grade,usp/ep/jp grade.


Related News: A strategic CDMO partner who can uphold a strong product manufacturing approach can positively influence timeline, quality, and costs of bringing the drug to market. N-Chlor-4-methyl-pentansaeureamid manufacturers As a global-risk medical practice transforming care of the neediest populations, our centers are located in underserved neighborhoods,” notes Faisel Syed, M.D., ChenMed National Director of Primary Care. (1R,2S,3E,7E,11S,13S)-2-((tert-butyldimethylsilyl)oxy)-13-methoxy-4,8,14,14-tetramethyl-12-oxabicyclo[9.2.1]tetradeca-3,7-dien-9-one suppliers High viral load in the respiratory tract correlates with severe illness and mortality in patients with COVID-19,” said Zhiqiang An, PhD, director of UTHealth Texas Therapeutics Institute, professor and Robert A. Welch Distinguished University Chair in Chemistry at McGovern Medical School at UTHealth, and faculty member at MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences and one of the corresponding authors on the study.
“Respiratory mucosal antibodies are key to clearing SARS-CoV-2 infection and reducing viral transmission and IgM antibodies are nature’s first line of defense against pathogens such as viruses. ((2-pentyl-2-((2-(tosyloxy)ethoxy)methyl)propane-1,3-diyl)bis(oxy))bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate) vendor & factory.